Trial Profile
AN OPEN-LABEL TRIAL OF REDUCED- DOSE PYLERA (BISMUTH, METRONIDAZOLE, TETRACYCLINE), AMOXICILLIN, AND ESOMEPRAZOLE IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2015
Price :
$35
*
At a glance
- Drugs Tripotassium dicitrato bismuthate/tetracycline/metronidazole (Primary) ; Amoxicillin; Esomeprazole
- Indications Helicobacter infections
- Focus Therapeutic Use
- 14 Jan 2015 According to the ClinicalTrials.gov record, status changed from recruiting to withdrawn prior to enrolment.
- 26 Feb 2014 New trial record